A look at Allergan’s Q3 2018 estimates

Allergan (AGN), a leading pharmaceutical company, is set to release its third quarter of 2018 earnings on October 30. Wall Street analysts estimate EPS of $4.03 on revenues of $3.88 billion.

Allergan’s Q3 2018 Earnings: Analysts’ Estimates

The above chart compares Allergan’s EPS and revenues since the first quarter of 2017 and provides the estimate for the third quarter of 2018.

Revenue estimates for Q3 2018

Allergan is expected to report a 3.8% decline in revenues to $3.88 billion for the third quarter compared to $4.03 billion for Q3 2017. Revenues are expected to decline due to lower sales of women’s health products, diversified brands, and central nervous system products. However, strong sales of specialized therapeutic products will substantially offset the decline in revenues.

Profitability estimates

Analysts are estimating that Allergan’s gross profit margin will decrease to 85.55% for the third quarter of 2018. That compares to a gross profit margin of 86.15% in Q3 2017. Its EBITDA margin is expected to decrease 1.6% to 49% in Q2 2018 compared to 50.6% in Q2 2017. The margin is expected to decrease marginally due to higher selling, general, and administrative expenses, partially offset by a decrease in R&D (research and development) expenses during the third quarter.

Its net adjusted income is expected to decrease to $1.37 billion in the third quarter of 2018 compared to $1.47 billion in Q3 2017.

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) holds 4.1% of its total investments in Allergan (AGN), 3.5% in Bristol-Myers Squibb (BMY), 7% in Johnson & Johnson (JNJ), and 9% in Pfizer (PFE).

Latest articles

20 Jun

Will Refiners’ Earnings Plunge in 2019?

WRITTEN BY Maitali Ramkumar

Wall Street analysts expect refining firms' earnings to fall in 2019. Delek US Holdings (DK) and Valero Energy’s (VLO) earnings are estimated to fall less than 10% in 2019. However, the EPS of Marathon Petroleum (MPC), HollyFrontier (HFC), and Phillips 66 (PSX) are expected to fall 20%–40% this year.

After remaining tepid for the first four months of the year, gold prices have taken off in a big way. The initial impetus was provided by a tweet made by President Donald Trump on May 5, which revived trade tensions in a big way.

20 Jun

How Are Charter’s Revenues Trending in 2019?

WRITTEN BY Ambrish Shah

In the first quarter, Charter Communications (CHTR) reported total revenues of $11.2 billion—a rise of 5.2% year-over-year and $7 million ahead of the consensus estimate.

This morning before the market opened, Tesla (TSLA) was trading on a negative note despite a sharp rise in index futures. As of 9:10 AM ET, Tesla stock had fallen 1.2% in the pre-market session to $234.74 after Goldman Sachs cut the target price on the company by about 21%.

The US-China trade war has already given a scare to Apple’s (AAPL) investors vis-à-vis the possibility of a 25% tariff on Apple goods being imported from its Chinese facilities. As a result, Apple might be considering shifting its plants out of China.

Yesterday, Greenlane Holdings (GNLN) fell a whopping 17.1%. The stock has now fallen 28% this month, and it hit its all-time low yesterday. Greenlane Holdings listed in April and priced its IPO at $17 per share. However, since the stock surged more than 25% after its listing, it has been a sorry story for Greenlane Holdings investors.